News

Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment

  • by

​ Abbott’s denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of Thais This approval builds on Abbott’s biosimilar portfolio in Asia Pacific, following… Read More »Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment